Effects of Dapagliflozin on myocardial performance in non-diabetic patients with Heart failure with reduced and mid-range ejection fraction (DAPA ECHO trial)
31 August 2024 (14:00 - 14:50)
Organised by: 

About the speakers

University of Siena, Siena (Italy)

University of Siena, Siena (Italy)
7 More presentations in this session

Doctor P. Wilson (Dallas, US)

Doctor A. Villaschi (Milan, IT)
Access the full session
The Event
ESC Congress 2024
31 August 2024
14:00 CET
You may be interested in
Congress Presentation
Congress Presentation
Congress Presentation





